Topic

Articles

Two FDA-funded projects at RCPE will look at real-time monitoring and control of drug tablet coating and developing a digital twin for drug production control.

RCPE Awarded FDA Funding to Develop Next-Generation Technology

The Phase III clinical trial of NVX-CoV2373 is expected to be fully enrolled in the UK and will begin in the US and Mexico by the end of November 2020.

Novavax COVID-19 Vaccine Trial Expands Enrollment

A clinical trial to enroll up to 10,000 volunteers across the UK will assess whether NVX-CoV2373 is effective in the prevention of COVID-19. 

Novavax Begins Phase III Efficacy Trial of COVID-19 Vaccine 

UK's Prime Minister visited the site of the country’s VMIC in Oxfordshire, and met the teams working at the forefront of the national COVID-19 response.

UK Prime Minister Visits Team Behind the Vaccines Manufacturing and Innovation Centre

A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents. 

Johnson & Johnson Launches Multi-Country Phase III Trial of Janssen’s COVID-19 Vaccine Candidate

The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.

Russia Completes Deals with India, Mexico, and Brazil for Sputnik V

Jennifer Markarian is manufacturing editor of BioPharm International.

Polymeric containers offer an alternative to glass.

Considering Materials for Vaccine Containers

Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.

AZD1222 Clinical Trials Resume in the UK

The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.

AstraZeneca Pauses Clinical Trial on COVID-19 Vaccine for Safety Review

As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.

Vaccine Developers Pledge to Stand with Science

Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain. 

Preparing Pandemic Vaccine Capacity

Editor of Pharmaceutical Technology Europe

Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.

Capsule Innovations: Speeding Up Drug Development

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing. 

Manufacturing Drug–Device Combination Products 

End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.

Making the Ideal Dosage Form

Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use. 

Solid-Dose Continuous Manufacturing Presses On 

Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.


Catalent to Manufacture Drug Substance for AstraZeneca’s COVID-19 Vaccine Candidate

EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.

EC Reaches Agreement with AstraZeneca on Purchase of COVID-19 Vaccine

CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.

CARBOGEN AMCIS Invests Heavily in Switzerland and France

Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial. 

Novavax Signs Term Sheet with UK Gov for COVID-19 Vaccine Doses

Hallie Forcinio is BioPharm International's packaging editor, editorhal@sbcglobal.net

Plastic primary packaging could help prevent supply chain shortages associated with high demand for COVID-19 vaccines.

Dosage Forms